Protagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of ICOTYDE for Moderate to Severe Plaque Psoriasis Treatment - Slideshow By Apex Shark · March 18, 2026 · 1 min read ptgxsa transcripts Source: seekingalpha.com